Hawk Ridge Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Hawk Ridge Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,200	Closed	-$861K	–	42
2023 Q1	$861K	Hold	21,200	–	–	0.05%	40
2022 Q4	$953K	Buy	+21,200	New	+$960K	0.06%	43

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Hawk Ridge Capital Management's TNDM Position: Q2 2023 in Review

Hawk Ridge Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 21,200 shares — an estimated $861K sold.

Hawk Ridge Capital Management first reported a position in TNDM in Q4 2022 and held it in 2 quarters. The position peaked at $953K in Q4 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Hawk Ridge Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Hawk Ridge Capital Management sold 21,200 Tandem Diabetes Care shares in Q2 2023, an estimated $861K.
Hawk Ridge Capital Management first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 2 quarters.
Hawk Ridge Capital Management's Tandem Diabetes Care position peaked at $953K in Q4 2022.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Hawk Ridge Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.